Core Viewpoint - RLX Technology plans to launch its self-developed oral nicotine product in the European and American markets in 2026, receiving positive feedback from global distributors [2]. Recent Events - The company is implementing the "Seeing Love: Guide Dog Partner Program," which will run from 2025 to 2026, with a donation of 4 million yuan for the training, medical care, and support of 20 guide dogs. The first batch of guide dogs has already been delivered and is currently in the adaptation training phase [2]. Performance and Business Situation - According to the Q3 2025 financial report, international business revenue accounts for 72% of the company's total revenue. The company aims to strengthen its position in the Asia-Pacific and European markets through localized products and retail networks [3]. Stock Performance - Over the past 7 days (as of February 12, 2026), RLX Technology's stock price has shown volatility, closing at $2.35, with a single-day decline of 3.69%. From February 9 to February 12, the stock price dropped by a cumulative 2.49%, with a price range of 4.56%. The highest price during this period was $2.46 on February 12, while the lowest was $2.35 on the same day. On February 12, the trading volume was approximately 1.906 million shares, with a trading value of about $4.588 million. The stock's performance over the past 5 days showed a decline of 0.84%, while the tobacco sector increased by 0.95%, and the Nasdaq index saw a slight increase of 0.25% [4].
雾芯科技计划2026年欧美上市口服尼古丁产品 国际业务营收占比达72%